Boston Scientific Corp (NYSE:BSX)
| 13.14 Data as of Jul 30 |  +0.25 / +1.94%Today’s Change | 10.54 Today|||52-Week Range 14.08 | +9.32% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | 213.0M | 267.0M | 168.0M | 179.0M | |
| Short Term Investment Cash | -651.0M | 54.0M | -60.0M | 10.0M | ||
| Cash & Short Term Investments | 213.0M | 267.0M | 207.0M | 217.0M | ||
| Receivables | Receivables | 1.3B | 1.2B | 1.2B | 1.3B | |
| Inventories | Inventories | 894.0M | 931.0M | 884.0M | 897.0M | |
| Current Assets | Other Current Assets | 1.2B | 661.0M | 714.0M | 590.0M | |
| Current Assets | 3.6B | 3.1B | 3.0B | 3.0B | ||
| Total Assets | Property, Plant and Equipment - Gross | 3.2B | 3.2B | 3.5B | 3.7B | |
| Depreciation | -1.5B | -1.5B | -2.0B | -2.1B | ||
| Intangible Assets | 16.5B | 16.2B | 12.3B | 11.6B | ||
| Other Assets | 16.8B | 16.5B | 12.5B | 12.0B | ||
| Total Assets | 22.1B | 21.3B | 17.2B | 16.6B | ||
| Liabilities | Accounts Payable | 184.0M | 203.0M | 232.0M | 246.0M | |
| Short Term Debt | 504.0M | 4.0M | 4.0M | 3.0M | ||
| Accrued Expenses | 740.0M | 695.0M | 732.0M | 776.0M | ||
| Other Current Liabilities | 1.5B | 1.1B | 1.1B | 1.1B | ||
| Other Liabilities | 2.6B | 1.8B | 1.8B | 1.8B | ||
| Total Liabilities | Long Term Debt | 4.9B | 4.3B | 4.3B | 4.2B | |
| Deferred Taxes | -1.6B | -1.8B | -1.7B | -1.4B | ||
| Other Liabilities | 1.5B | 1.8B | 2.2B | 2.0B | ||
| Total Liabilities | 10.8B | 9.9B | 10.3B | 10.0B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 11.3B | 11.4B | 6.9B | 6.5B | ||
| Total Shareholder Equity | 11.3B | 11.4B | 6.9B | 6.5B | ||
| Share Information | Common Shares Outstanding | 1.5B | 1.4B | 1.4B | 1.3B | |
| Addtl. Info. | No data currently available for this section. | |||||
.
